Equity Components [Axis]
Common Stock [Member]
Preferred Stock [Member]
Class of Stock [Axis]
Series F Preferred Stock [Member]
Subscription Receivable Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Option Exchange Agreement [Member]
Sale of Stock [Axis]
Private Placement [Member]
Legal Entity [Axis]
Sanovas Ophthalmology LLC [Member]
Antidilutive Securities [Axis]
Stock Options [Member]
Warrant [Member]
Diopsys, Inc. [Member]
Related Party [Axis]
Original Employment Agreement [Member]
Mr. Gerrans [Member]
Amended and Restated Employment Agreement [Member]
Halo Management LLC [Member]
Plan Name [Axis]
2017 Equity Incentive Plan [Member]
Statistical Measurement [Axis]
Maximum [Member]
Award Type [Axis]
Title of Individual [Axis]
CEO and Consultant [Member]
Error Correction, Type [Axis]
Mathematical Error [Member]
Sanovas Offering [Member]
Tax Period [Axis]
No Expiration Date [Member]
Expire in 2034 [Member]
Expire in 2030 [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Consulting Firm [Member]
Sanovas Ophthalmology LLC [Member]
Exercise Price Range [Axis]
Exercise Price One [Member]
Exercise Price Two [Member]
Directors [Member]
Halo Management Group LLC [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Statement of Financial Position [Abstract]
ASSETS
Current Assets
Cash
Due from Sanovas
Deferred Offering Costs
Total Current Assets
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities
Shareholder’s Loans
Accounts Payable
Due to Sanovas
Accrued Interest
Total Liabilities
Stockholders’ Deficit:
Preferred stock, Value
Common stock, Value
Additional paid in capital
Preferred stock subscription receivable
Accumulated deficit
Total stockholders’ deficit
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Revenue
Costs and expenses
Administrative
Research and Development
Stock-based compensation
Total Operating Expenses
(Loss) from operations
Interest expense
Net Loss
Net Loss per share - basic and diluted
Weighted average number of common shares outstanding during the period- basic and diluted
Statement [Table]
Statement [Line Items]
Beginning balance, value
Beginning balance, shares
Stock based compensation
Exercise of stock options
Exercise of stock options, shares
Exercise of warrants
Exercise of warrants, shares
Capital contribution by Sanovas (Note C)
Retirement of due to Sanovas through the issuance of shares of common stock to Sanovas Ophthalmology LLC
Retirement of due to Sanovas through the issuance of shares of common stock to Sanovas Ophthalmology LLC, shares
Stock purchased by investors
Stock purchased by investors, shares
Deemed dividend
Costs of stock sales
Net loss
Ending balance, value
Ending balance, shares
Statement of Cash Flows [Abstract]
Cash Flows From Operating Activities
Stock based compensation expense
Costs and expenses paid on behalf of Company by Sanovas, net
Changes in operating assets and liabilities:
Increase in current assets
Increase in accounts payable
Increase in accrued interest
Total Adjustments
Net cash used in operating activities
Cash Flows From Financing Activities
Change in stockholders refund payable, net
Proceeds from common stock sold, net of costs
Proceeds from shareholder loans
Proceeds from exercise of warrants
Proceeds from exercise of options
Net cash provided by financing activities
Net increase (decrease) in cash
Cash at beginning of period
Cash at end of period
Supplemental information:
Retirement of due to Sanovas to capital through the issuance of common stock to Sanovas Ophthalmology LLC (Note C)
Capital contribution by Sanovas
Accounting Policies [Abstract]
HISTORY, BUSINESS PURPOSE, LIQUIDITY AND GOING CONCERN
SIGNIFICANT ACCOUNTING POLICIES
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS
Equity [Abstract]
COMMON AND PREFERRED STOCK
Stock Plan
STOCK PLAN
Warrants
WARRANTS
Income Tax Disclosure [Abstract]
INCOME TAXES
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Basis of Presentation
Cash Equivalents
Deferred Offering Costs
Use of Estimates
Income Taxes
Income (Loss) Per Common Share
Stock-based compensation
Research and Development costs
Recent Accounting Pronouncements
SCHEDULE OF RELATED PARTY TRANSACTIONS
SCHEDULE OF STOCK OPTION ACTIVITY
SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE
SCHEDULE OF STOCK OPTIONS FAIR VALUE ASSUMPTIONS
SCHEDULE OF WARRANTS FAIR VALUE ASSUMPTIONS
SCHEDULE OF WARRANTS ACTIVITY
SCHEDULE OF WARRANTS OUTSTANDING
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Options to purchase shares, percentage
Proceeds from issuance of private offering
Capital contribution
Value of shares issuance to offset due amounts
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Unrecognized tax benefits
Accrued penalties and interest
Anti-dilutive securities excluded from computation of earning per shares
Balance due from Sanovas - beginning of period
Costs paid by Sanovas on the Company's behalf
Costs of Sanovas allocated to the Company
Repayment of costs charged by Sanovas to the Company
Subtotal
Capital Contribution by Sanovas
Retirement of due to Sanovas through the issuance of 390,358 and 358,126 shares of common stock to Sanovas Ophthalmology, respectively
Balance due to Sanovas - ending of period
Balance due from Sanovas - beginning of period
Number of issuance of shares due to retirement
Schedule of Related Party Transactions, by Related Party [Table]
Related Party Transaction [Line Items]
Related party cost
Value of shares issuance to offset due amounts
Schedule of Stock by Class [Table]
Class of Stock [Line Items]
Number of restricted shares issued
Percentage of shares issued
Number of shares issued during period
Shares issued price per share
Sale of stock, shares issued
Offering costs
Due to related parties
Preferred stock, voting right
Preferred stock, dividend
Preferred stock, conversion price
Proceeds from issuance of preferred stock
Schedule Of Stock Option Activity
Stock Options, Outstanding, Beginning Balance
Weighted Average Exercise Price, Beginning Balance
Stock Options, Granted
Weighted Average Exercise Price, Granted
Stock Options, Canceled
Weighted Average Exercise Price, Canceled
Stock Options, Exercised
Weighted Average Exercise Price, Exercised
Stock Options, Outstanding, Ending Balance
Weighted Average Exercise Price, Ending Balance
Schedule Of Stock Options Outstanding And Exercisable
Exercise Price
Number of Options Outstanding
Weighted Average Remaining Contractual Life
Number of Options Exercisable
Risk-free interest rates
Expected life in years
Expected volatility
Expected dividend yield
Fair value common stock
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock shares reserved for future issuance
Number of stock options to purchase common stock
Exercise price
Aggregate fair value of stock options
Unrecognized compensation expense
Weighted-average period for recognition
Fair value of share price
Options, vesting period
Schedule Of Warrants Activity
Warrants, Outstanding, Beginning Balance
Weighted Average Exercise Price, Beginning Balance
Warrants, Granted
Weighted Average Exercise Price, Granted
Warrants, Canceled
Weighted Average Exercise Price, Canceled
Warrants, Exercised
Weighted Average Exercise Price, Exercised
Warrants, Outstanding, Ending Balance
Weighted Average Exercise Price, Ending Balance
Share-based Payment Arrangement, Option, Exercise Price Range [Table]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price
Number Outstanding
Weighted Average Remaining Contractual Life
Number Exercisable
Net amount of shares issued
Issuance of warrants to purchase common stock
Warrant exercise price
Decrease in awards of common stock
Warrants estimated fair value
Number of shares issued
Offering value of common stock designated
Amount contributed to captial
Warrants term
Dividend yield, percentage
Unrecognized compensation expenses
Operating Loss Carryforwards [Table]
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, limitation on use
Operating loss carryforwards
Deferred tax assets, net
Changes in valuation allowance
Subsequent Event [Table]
Subsequent Event [Line Items]
Sale of stock price per share
Number of shares rescinded
Option Exchange Agreement [Member].
Sanovas Ophthalmology LLC [Member].
2017 Equity Incentive Plan [Member].
Stock Options [Member].
Diopsys, Inc. [Member]
Consulting Firm [Member]
Original Employment Agreement [Member].
Mr. Gerrans [Member]
Amended and Restated Employment Agreement [Member].
Sanovas Ophthalmology LLC [Member]
Halo Management LLC [Member]
No Expiration Date [Member]
Expire in 2034 [Member]
Expire in 2030 [Member]
Capital contribution.
Shares issued for repayment of debt value.
Shares issued for repayment of debt shares.
Change in stockholders refund payable.
Deferred Offering Costs [Policy Text Block]
Due to related parties.
Due to related parties gross.
Stock issued during period shares retirement.
Stock issued during period value retirement.
Stock Plan Disclosure [Text Block].
Fair value of share price.
Warrants Disclosure [Text Block]
Share Based Compensation Arrangement By Share Based Payment Award Non-Options Outstanding Weighted Average Exercise Price.
Share Based Compensation Arrangement By Share Based Payment Award Non-Options Outstanding Weighted Average Exercise Price Granted.
Share Based Compensation Arrangement By Share Based Payment Award Non-Options Outstanding Weighted Average Exercise Price Cancelled.
Share Based Compensation Arrangement By Share Based Payment Award Non-Options Outstanding Weighted Average Exercise Price Exercised.
Number of shares rescind during period.
Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Exercisable Number.
Schedule of Warrant Outstanding [TableText Block]
Adjustments to Additional paid in capital capital contribution.
CEO and Consultant [Member]
Mathematical Error [Member]
Sanovas Offering [Member]
Offering value of stock designated.
Deemed dividend.
Directors [Member]
Halo Management Group LLC [Member]
Subscription Receivable Preferred Stock [Member]
Sanovas Ophthalmology LLC [Member] [Default Label]
Assets, Current
Assets
Liabilities
Preferred Stock, Shares Subscribed but Unissued, Subscriptions Receivable
Stockholders' Equity Attributable to Parent
Liabilities and Equity
Operating Expenses
Operating Income (Loss)
Shares, Outstanding
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
Increase (Decrease) in Other Current Assets
Net Cash Provided by (Used in) Operating Activities
ChangeInStockholdersRefundPayable
Net Cash Provided by (Used in) Financing Activities
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
DeferredOfferingCostsPolicyTextBlock
Compensation Related Costs, Policy [Policy Text Block]
DueToRelatedParties
Debt Conversion, Converted Instrument, Shares Issued
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceGranted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceCancelled
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExercised
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms